Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
The Annals of Pharmacotherapy|March 19, 2011
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorderEric Q Wu, Andrew P Yu, Veronique Lauzon, et al.Journal of Medical Economics|June 23, 2011
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costsAndrew P Yu, Rym Ben-Hamadi, Eric Q Wu, et al.Current Medical Research and Opinion|August 3, 2007
Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record dataAndrew P Yu, Eric Q Wu, Howard G Birnbaum, et al.The Journal of Clinical Psychiatry|February 8, 2011
Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy changeJames Signorovitch, Howard Birnbaum, Rym Ben-Hamadi, et al.Journal of the American Academy of Dermatology|January 17, 2012
Risks of developing psychiatric disorders in pediatric patients with psoriasisAlexa B Kimball, Eric Q Wu, Annie Guérin, et al.Journal of Medical Economics|May 8, 2013
A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosusHong Kan, Annie Guerin, Michael S Kaminsky, et al.Current Medical Research and Opinion|August 3, 2010
Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievementJoanne Chang, Weiyi Yang, Thomas Fellers, et al.Current Medical Research and Opinion|November 27, 2008
Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care populationEric Q Wu, Steve R Feldman, Lei Chen, et al.Respiratory Medicine|August 3, 2011
Clinical and economic outcomes of multiple versus single long-acting inhalers in COPDAndrew P Yu, Annie Guérin, Diego Ponce de Leon, et al.Dermatology (Basel, Switzerland)|February 5, 2010
High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practiceJean-Hilaire Saurat, Annie Guérin, Andrew P Yu, et al.Pageof 6